Common Contracts

SECURITIES AND EXCHANGE COMMISSION CONFIDENTIAL TREATMENT REQUESTED UNDER Collaboration and License Agreement by and between RA PHARMACEUTICALS, INC. and MERCK SHARP & DOHME CORP. April 1, 2013

Collaboration and License Agreement • September 30th, 2016 • Ra Pharmaceuticals, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Collaboration and License Agreement
• Filed
  September 30th, 2016
• Company
  Ra Pharmaceuticals, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Collaboration and License Agreement (this “Agreement”), dated as of April 1, 2013 (the “Effective Date”), is made by and between Ra Pharmaceuticals, Inc., a Delaware corporation (“Ra”) and Merck Sharp & Dohme Corp., a New Jersey corporation (“Merck”).

SECURITIES AND EXCHANGE COMMISSION CONFIDENTIAL TREATMENT REQUESTED UNDER Collaboration and License Agreement by and between RA PHARMACEUTICALS, INC. and MERCK SHARP & DOHME CORP. April 1, 2013

Collaboration and License Agreement • August 17th, 2016 • Ra Pharmaceuticals, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Collaboration and License Agreement
• Filed
  August 17th, 2016
• Company
  Ra Pharmaceuticals, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Collaboration and License Agreement (this “Agreement”), dated as of April 1, 2013 (the “Effective Date”), is made by and between Ra Pharmaceuticals, Inc., a Delaware corporation (“Ra”) and Merck Sharp & Dohme Corp., a New Jersey corporation (“Merck”).